Verenium Corp - VRNM - reported an agreement with Tate & Lyle for the use of one of its proprietary enzyme products in the development of novel food ingredients. Under the terms of the agreement, Verenium receives $1.5 million in near term milestone payments, revenues from enzyme product sales, and a royalty on Tate & Lyle’s future sales. On its Fourth Quarter Fiscal 2011, Align Technology Inc -ALGN - posted record net revenues of $128.9 million, a 2.4% increase sequentially and 38.8% year-over-year. PanGeo Subsea Inc and Global Geophysical Services Inc - GGS - reported that they have entered into an agreement for the development and commercialization of the Acoustic Zoom product line. ********************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Diasclaimer at http://www.crwenewswire.com/disclaimer)
投稿者: karmastock
投稿日時:2012-01-31 10:23:53.0
視聴回数:544回
お気に入り登録:0
カテゴリ:
ビジネス全般
タグ:
VRNM
ALGN
GGS
Nasdaq:VRNM
Nasdaq:ALGN
NYSE:GGS